Kaleido Biosciences

$12.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+3.32%) Today

+$0.18 (+1.44%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KLDO and other stocks, options, and ETFs commission-free!

About KLDO

Kaleido Biosciences, Inc. engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. It offers microbiome metabolic therapies (MMT) which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA. The listed name for KLDO is Kaleido Biosciences, Inc. Common Stock.

CEO

Daniel L. Menichella

Employees

Headquarters

Lexington, Massachusetts

Founded

2015

Market Cap

469.16M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

160.49K

High Today

$12.70

Low Today

$11.74

Open Price

$12.00

Volume

134.29K

52 Week High

$14.44

52 Week Low

$2.82

Collections

KLDO Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 1, Pre-Market